Oral spray helps cannabis users cut back: study
Aussie trial finds first real-world evidence that nabiximols helps counter addiction
19th July 2019
Patients with cannabis dependence may reduce their use of the illicit drug with the aid of the cannabis agonist nabiximols alongside CBT counselling, an Australian study shows.
A randomised placebo-controlled trial in NSW has found that patients using the oromucosal nabiximols spray, Sativex, reduce their number of days using illicit cannabis.
Researchers say it’s the first real-world evidence that nabiximols helps heavy recreational cannabis users cut back on daily use.
Lead author Professor Nick Lintzeris, an addiction medicine specialist, says the medication affords